KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Current Assets: 2020-2024

Historic Current Assets for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $602.7 million.

  • Ginkgo Bioworks Holdings' Current Assets fell 23.61% to $506.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $506.1 million, marking a year-over-year decrease of 23.61%. This contributed to the annual value of $602.7 million for FY2024, which is 39.83% down from last year.
  • According to the latest figures from FY2024, Ginkgo Bioworks Holdings' Current Assets is $602.7 million, which was down 39.83% from $1.0 billion recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Current Assets ranged from a high of $1.7 billion in FY2021 and a low of $426.5 million during FY2020.
  • Moreover, its 3-year median value for Current Assets was $1.0 billion (2023), whereas its average is $1.0 billion.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Current Assets surged by 303.96% in 2021, and later crashed by 39.83% in 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Current Assets (Yearly) stood at $426.5 million in 2020, then spiked by 303.96% to $1.7 billion in 2021, then declined by 15.84% to $1.5 billion in 2022, then tumbled by 30.92% to $1.0 billion in 2023, then crashed by 39.83% to $602.7 million in 2024.